Čájehuvvojit 1 - 1 oktiibuot 1 bohtosis ohcui for the PRESS XII study group', ohcanáigi: 0,02s Aiddostahte ozu
  1. 1
    Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study)

    Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double bli... Dahkki Manjunath Krishnappa, Kishor Patil, Krupi Parmar, Purav Trivedi, Nirali Mody, Chintan Shah, Khushboo Faldu, Sanjay Maroo, for the PRESS XII study group, Deven Parmar

    Almmustuhtton 2020-06-01
    Viečča ollesdeavstta
    Artihkal

Ohcanreaiddut: